Tolerability of palbociclib in younger and older patients with advanced breast cancer.

Dennison, Taylor; Heiling, Hillary; Deal, Allison; Brunk, Kelly; Kemper, Ryan; Crona, Daniel J; Faso, Aimee

Dennison, Taylor; Heiling, Hillary; Deal, Allison; Brunk, Kelly; Kemper, Ryan; Crona, Daniel J; Faso, Aimee.

Afiliação

Dennison T; Department of Pharmacy, 2332University of North Carolina Medical Center, Chapel Hill, NC, USA.
Heiling H; 169113University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Deal A; 169113University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
Brunk K; Department of Pharmacy, 145762University of Kansas Cancer Center, Kansas, KS, USA.
Kemper R; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, 15521University of North Carolina, Chapel Hill, NC, USA.
Crona DJ; Department of Pharmacy, 2332University of North Carolina Medical Center, Chapel Hill, NC, USA.
Faso A; 169113University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.

J Oncol Pharm Pract ; 29(1): 96-104, 2023 Jan.

Article em En | MEDLINE | ID: mdl-34751060

Assuntos

Neoplasias da Mama; Neutropenia; Humanos; Feminino; Neoplasias da Mama/tratamento farmacológico; Neoplasias da Mama/metabolismo; Receptor ErbB-2/metabolismo; Receptores de Estrogênio/metabolismo; Estudos Retrospectivos; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos; Neutropenia/tratamento farmacológico

Palavras-chave

Palbociclib; advanced breast cancer; age; cyclin-dependent kinase 4/6 inhibitor; neutropenia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Neutropenia Limite: Female / Humans Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google